Source: Verano.
  • Verano (VRNO) will open MÜV Sebring, its 52nd Florida dispensary, on July 16, 2022
  • The area boasts an average daily traffic count of 40,000
  • The company now operates 106 dispensaries and 13 cultivation and processing facilities across the U.S.
  • Verano is a leading, vertically integrated cannabis operator present in 14 U.S. states
  • Verano (VRNO) is down by 2.24 per cent trading at $8.31 per share

Verano (VRNO) will open MÜV Sebring, its 52nd Florida dispensary, on July 16, 2022.

The store is located in a busy thoroughfare with an average daily traffic count of 40,000.

According to Florida’s Office of Medical Marijuana Use, there are over 736,000 qualified medical cannabis patients in the state.

Florida’s medical cannabis sales are projected to reach US$2.5B by 2026 (MJBiz Factbook 2022).

The company now operates 106 dispensaries and 13 cultivation and processing facilities across the U.S.

“We are excited and ready to introduce the area’s medical marijuana patient community to the MÜV retail experience and our premium cannabis products,” said John Tipton, President of Verano.

Verano is a leading, vertically integrated cannabis operator present in 14 U.S. states.

Verano (VRNO) is down by 2.24 per cent trading at $8.31 per share as of 10:21 am EST.

More From The Market Online

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.